GENB-120

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameGENB-120

Drug Alias NameGENB-120

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Integrin Subunit Beta 4Tumor-associated calcium signal transducer 2 modulators

TargetsIntegrin Subunit Beta 4Tumor-associated calcium signal transducer 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenome & Company Inc

China Registration ClassN/A

Develop Information

Active CompaniesGenome & Company Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A